Aviva
TRNS icon

Aviva’s Transcat TRNS Stock Holding History

Aviva’s Portfolio TRNS Stock Details TRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,997
Closed -$1.62M – 1108
2022
Q1 		$1.62M Buy
+19,997
New +$1.63M 0.01% 886

Other funds holding TRNS

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aviva's TRNS Position: Q2 2022 in Review

Aviva sold out of Transcat (TRNS) in Q2 2022, closing a stake of 19,997 shares — an estimated $1.62M sold.

Aviva first reported a position in TRNS in Q1 2022 and held it in 1 quarter. The position peaked at $1.62M in Q1 2022. 99 funds tracked by Wall St. Rank hold TRNS as of Q2 2022.

  • Aviva reported no remaining Transcat position as of Q2 2022 after selling out during the quarter.
  • Aviva sold 19,997 Transcat shares in Q2 2022, an estimated $1.62M.
  • Aviva first reported a position in Transcat in Q1 2022 and held it in 1 quarter.
  • Aviva's Transcat position peaked at $1.62M in Q1 2022.
  • 99 funds tracked by Wall St. Rank held Transcat as of Q2 2022.

Based on Aviva's 13F filing for Q2 2022, filed 4 Aug 2022.